Clinical trials · Orlando, FL
Parkinson’s disease clinical trials in Orlando
We’re tracking 12 recruiting parkinson’s disease studies with a site in or near Orlando — including Phase 1, Phase 2, Phase 2/Phase 3, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near Orlando
- NCT07174310RecruitingPhase 3
Prasinezumab for early Parkinson's disease
This study tests a new medication called prasinezumab, given through a vein (IV), to see if it can slow the progression of early-stage Parkinson's disease. It is for people who are on only one Parkinson's medication and have not yet developed motor complications.
Orlando, FloridaAges 50–85 - NCT06680830RecruitingPhase 2
Testing NEU-411 for early Parkinson's with LRRK2 gene change
This trial tests an experimental drug called NEU-411 for people with early Parkinson's disease who have a specific genetic change (LRRK2). It aims to see if the drug can slow the disease progression.
Orlando, FloridaAges 40–80 - NCT06765668RecruitingPhase 4
Study of CREXONT for Parkinson's with wearing-off episodes
This study tests how well CREXONT, an extended-release form of carbidopa-levodopa, controls symptoms in people with Parkinson's who experience predictable 'off' periods when their regular medication wears off. The goal is to see if it can reduce the daily hours of poor mobility.
Orlando, FloridaAges 18 years+ - NCT07330258Recruiting
Observing Parkinson's over time in people still having movement symptoms
This study follows people with Parkinson's disease who still have movement symptoms despite taking medication. It aims to understand how the disease changes over time, which could help improve future treatments.
Orlando, FloridaAges 45–75 - NCT07428447Recruiting
Skin test to see if essential tremor may progress to Parkinson's
This study uses a small skin sample to look for a protein linked to Parkinson's disease. It aims to help people with essential tremor understand their risk of developing Parkinson's, which could guide future care.
Orlando, FloridaAges 50–85 - NCT06809400RecruitingPhase 1
Study of LY4006896 for Parkinson's disease
This study tests an investigational drug called LY4006896 in healthy people and in people with Parkinson's disease. It aims to see if the drug is safe and how it affects the body, which may help in developing a new treatment for Parkinson's.
Orlando, FloridaAges 30–85 - NCT07432958RecruitingPhase 2
Study of AP-472 with levodopa for Parkinson's motor fluctuations
This trial tests an experimental drug called AP-472, taken alongside your regular Parkinson's medications, to see if it can reduce the amount of "OFF" time you experience each day when symptoms return between doses of levodopa.
Orlando, FloridaAges 30–80 - NCT07284784RecruitingPhase 2/Phase 3
Buntanetap for Parkinson's disease study
This trial tests an investigational drug called buntanetap in people with Parkinson's disease. It aims to see if the drug can improve symptoms. There are two groups: those who've taken buntanetap before (Cohort 1) and those with a deep brain stimulator (DBS) implant for at least a year (Cohort 2).
Winter Park, FloridaAges 40–85 - NCT07422675RecruitingPhase 1
Study of a new treatment for Parkinson's with motor fluctuations
This study tests a new single-dose treatment for Parkinson's disease to see if it can help reduce 'off' time—when medication wears off and symptoms return. It is for people who experience motor fluctuations and are already on a stable medication routine.
Maitland, FloridaAges 40–80 - NCT06976268RecruitingPhase 2/Phase 3
Testing BHV-8000 for early Parkinson's disease
This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.
Maitland, FloridaAges 40–80 - NCT07804615RecruitingPhase 2
Investigational drug for tremor from Parkinson's disease
This study is testing an investigational drug for Parkinson's-related tremor (shaking). It aims to see if the drug can help reduce tremor in people whose symptoms are not fully controlled by current treatment.
Altamonte Springs, FloridaAges 18–65 - NCT05266417RecruitingPhase 2
Nasal insulin plus glutathione for Parkinson’s symptoms
This Phase 2 study tests whether adding nasal insulin and glutathione can improve Parkinson’s disease symptoms and function. You would use study medicine through the nose while keeping your other treatments mostly the same during the trial.
The Villages, FloridaAges 30 years+
Hear when a new Parkinson’s disease trial opens near Orlando, FL
We’ll email you when one opens near Orlando, FL — at most once a week, no account needed, unsubscribe anytime.
Parkinson’s disease trials in other cities
Where these studies are running near Orlando
Institutions with a site for the recruiting parkinson’s disease studies listed above.
- Charter Research · 3 studies
- Neurology One · 3 studies
- K2 Medical Research · 2 studies
- Accel Clinical Sites-Georgia LLC dba Accel Research Sites-Lake Oconee CRU
- AdventHealth Neuroscience Institute
- AdventHealth Orlando
- Conquest Research
- K2 Medical Research - The Villages
What taking part in a parkinson’s disease study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting parkinson’s disease studies in Florida.
Common questions
- Are there parkinson’s disease clinical trials near Orlando?
- Yes. We're currently tracking 12 recruiting parkinson’s disease studies with a site near Orlando, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a parkinson’s disease study near Orlando?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Orlando to take part?
- Not necessarily. These studies have a site near Orlando, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a parkinson’s disease trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New parkinson’s disease studies open near Orlando regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.